JP2018506538A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506538A5
JP2018506538A5 JP2017541999A JP2017541999A JP2018506538A5 JP 2018506538 A5 JP2018506538 A5 JP 2018506538A5 JP 2017541999 A JP2017541999 A JP 2017541999A JP 2017541999 A JP2017541999 A JP 2017541999A JP 2018506538 A5 JP2018506538 A5 JP 2018506538A5
Authority
JP
Japan
Prior art keywords
mycobacterium
appendix
pharmaceutically acceptable
infection
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541999A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018506538A (ja
JP6771472B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/050775 external-priority patent/WO2016128948A1/en
Publication of JP2018506538A publication Critical patent/JP2018506538A/ja
Publication of JP2018506538A5 publication Critical patent/JP2018506538A5/ja
Application granted granted Critical
Publication of JP6771472B2 publication Critical patent/JP6771472B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541999A 2015-02-12 2016-02-12 4−置換ベンゾオキサボロール化合物及びその使用 Expired - Fee Related JP6771472B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP15382056.8 2015-02-12
EP15382055.0 2015-02-12
EP15382055 2015-02-12
EP15382056 2015-02-12
EP15382054.3 2015-02-12
EP15382054 2015-02-12
PCT/IB2016/050775 WO2016128948A1 (en) 2015-02-12 2016-02-12 4 -substituted benzoxaborole compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2018506538A JP2018506538A (ja) 2018-03-08
JP2018506538A5 true JP2018506538A5 (enExample) 2019-03-14
JP6771472B2 JP6771472B2 (ja) 2020-10-21

Family

ID=55409879

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017542053A Pending JP2018506540A (ja) 2015-02-12 2016-02-12 ベンゾオキサボロール化合物及びその使用
JP2017541999A Expired - Fee Related JP6771472B2 (ja) 2015-02-12 2016-02-12 4−置換ベンゾオキサボロール化合物及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017542053A Pending JP2018506540A (ja) 2015-02-12 2016-02-12 ベンゾオキサボロール化合物及びその使用

Country Status (36)

Country Link
US (3) US20180037595A1 (enExample)
EP (2) EP3256480A1 (enExample)
JP (2) JP2018506540A (enExample)
KR (2) KR20170117158A (enExample)
CN (2) CN107548398A (enExample)
AU (3) AU2016217508A1 (enExample)
BR (2) BR112017017211B1 (enExample)
CA (2) CA2976030C (enExample)
CL (2) CL2017002060A1 (enExample)
CO (2) CO2017008816A2 (enExample)
CR (2) CR20170371A (enExample)
CY (1) CY1123687T1 (enExample)
DK (1) DK3256479T3 (enExample)
DO (2) DOP2017000189A (enExample)
EA (2) EA036516B1 (enExample)
ES (1) ES2821951T3 (enExample)
HR (1) HRP20201597T1 (enExample)
HU (1) HUE051113T2 (enExample)
IL (2) IL253864B (enExample)
LT (1) LT3256479T (enExample)
MA (2) MA41495A (enExample)
MX (2) MX379057B (enExample)
MY (1) MY194004A (enExample)
NZ (1) NZ734379A (enExample)
PE (2) PE20171432A1 (enExample)
PH (2) PH12017501427A1 (enExample)
PL (1) PL3256479T3 (enExample)
PT (1) PT3256479T (enExample)
RS (1) RS60885B1 (enExample)
SG (2) SG11201706511TA (enExample)
SI (1) SI3256479T1 (enExample)
SM (1) SMT202000565T1 (enExample)
TW (2) TWI730953B (enExample)
UA (1) UA120527C2 (enExample)
WO (2) WO2016128949A1 (enExample)
ZA (1) ZA201705456B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160251380A1 (en) * 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
DK3621609T3 (da) 2017-05-08 2022-08-29 Glaxosmithkline Ip Dev Ltd Sanfetrinem eller et salt eller ester deraf til anvendelse i behandling af mykobakterieinfektion
MX2020005464A (es) 2017-11-30 2020-12-03 Boragen Inc Compuestos de benzoxaborol y formulaciones de los mismos.
EP3836938A4 (en) 2018-08-18 2022-05-11 Boragen, Inc. SOLID FORMS OF SUBSTITUTED BENZOXAZOLE AND COMPOSITIONS THEREOF
CN110441344B (zh) * 2019-06-25 2020-09-29 北京大学 一种基于固体核磁共振技术检测rna结构的方法
CA3239097A1 (en) 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
JP2025520237A (ja) * 2022-06-23 2025-07-03 ミクウルク ファーマシューティカルズ, インコーポレイテッド ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
KR20240150582A (ko) 2023-04-08 2024-10-15 김태서 맥세이프 배터리팩을 포함한 아이폰 케이스

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411587D0 (en) * 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
WO1998024753A1 (en) 1996-12-02 1998-06-11 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US7446236B2 (en) 2002-12-02 2008-11-04 Solvias Ag Catalytic hydrogenation of carbon-heteroatom double bonds
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
ES2872962T3 (es) 2005-02-16 2021-11-03 Anacor Pharmaceuticals Inc Boronoftalidas para uso terapéutico
JP5084717B2 (ja) 2005-03-08 2012-11-28 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ キラル・ビスオキサゾリン触媒
TWM325238U (en) * 2006-12-29 2008-01-11 Universal Scient Ind Co Ltd Voltage regulator and voltage regulating system
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
SG172040A1 (en) 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
AU2011237681B2 (en) * 2010-04-07 2015-01-22 Glaxosmithkline Llc Process for preparing benzoxaboroles
DK2613788T3 (en) 2010-09-07 2017-08-07 Anacor Pharmaceuticals Inc BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS
US8530452B2 (en) 2011-12-22 2013-09-10 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
CN102739587B (zh) 2012-06-16 2014-05-21 天地融科技股份有限公司 音频数据传输方法
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
US20160251380A1 (en) * 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2016527321A5 (enExample)
NZ716350A (en) Tricyclic benzoxaborole compounds and uses thereof
HRP20201597T1 (hr) 4-supstituirani spojevi benzoksaborola i njihova upotreba
US11254689B2 (en) Compounds
JP7123074B2 (ja) マイコバクテリア感染の処置において使用するためのサンフェトリネム、その塩、またはそのエステル
CN108883114B (zh) 抗结核药物
JP2020519592A5 (enExample)
TH1601000677A (th) สารประกอบไทรไซคลิคเบนโซซะโบโรลและการใช้ของมัน
BR112020003192B1 (pt) Compostos da fórmula (i), uso dos ditos compostos para o tratamento de infecção micobacteriana ou de doença causada pela mesma, composição farmacêutica e combinação que compreende os compostos